Phreesia, Inc. (NYSE:PHR) Shares Sold by Bellevue Group AG

Bellevue Group AG decreased its stake in Phreesia, Inc. (NYSE:PHR - Free Report) by 4.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 405,693 shares of the company's stock after selling 16,713 shares during the period. Bellevue Group AG owned approximately 0.70% of Phreesia worth $10,207,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in PHR. Barclays PLC boosted its stake in shares of Phreesia by 83.6% during the 3rd quarter. Barclays PLC now owns 94,929 shares of the company's stock worth $2,163,000 after acquiring an additional 43,225 shares in the last quarter. Franklin Resources Inc. raised its holdings in Phreesia by 3.0% during the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company's stock worth $31,495,000 after purchasing an additional 42,973 shares during the last quarter. Wesbanco Bank Inc. boosted its position in Phreesia by 76.9% during the fourth quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company's stock worth $1,157,000 after purchasing an additional 20,000 shares in the last quarter. R Squared Ltd purchased a new position in shares of Phreesia in the fourth quarter valued at $30,000. Finally, Rhumbline Advisers increased its position in shares of Phreesia by 7.4% in the fourth quarter. Rhumbline Advisers now owns 83,631 shares of the company's stock valued at $2,104,000 after buying an additional 5,756 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company's stock.

Insider Buying and Selling at Phreesia

In other news, insider Yvonne Hui sold 1,878 shares of the business's stock in a transaction on Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total transaction of $44,790.30. Following the completion of the sale, the insider now directly owns 28,449 shares of the company's stock, valued at $678,508.65. The trade was a 6.19 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP David Linetsky sold 4,499 shares of the stock in a transaction on Wednesday, April 16th. The stock was sold at an average price of $23.73, for a total value of $106,761.27. Following the completion of the transaction, the senior vice president now directly owns 217,239 shares in the company, valued at $5,155,081.47. This trade represents a 2.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 111,940 shares of company stock worth $3,103,023 in the last 90 days. 5.80% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Citigroup boosted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a research report on Friday, January 10th. KeyCorp lowered their price target on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Piper Sandler reissued an "overweight" rating and set a $33.00 price objective (up from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Royal Bank of Canada raised Phreesia from a "sector perform" rating to an "outperform" rating and upped their target price for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Finally, Canaccord Genuity Group raised their price target on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Thursday, March 13th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia presently has an average rating of "Buy" and an average target price of $31.33.

Phreesia Trading Up 0.5 %

Shares of NYSE:PHR traded up $0.13 during midday trading on Wednesday, reaching $24.39. The company's stock had a trading volume of 507,501 shares, compared to its average volume of 431,778. The firm has a market cap of $1.43 billion, a price-to-earnings ratio of -16.59 and a beta of 0.74. The business has a 50 day moving average price of $25.13 and a 200 day moving average price of $24.60. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $30.53. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.